NASDAQ:ACHV

Achieve Life Sciences Stock Predictions

Healthcare > Biotechnology

Buy ACHV

*Your capital is at risk

$4.92

-0.110 (-2.19%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ACHV Prediction Chart

ACHV Predictions History

Latest community submissions for ACHV.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Mar 7, 2019	$2.74 -94.52%	$2.50	V	90.40%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ACHV with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ACHIEVE LIFE SCIENCES, INC.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol....

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by